Vigilancia Tecnológica

This document relates to methods and materials for assessing and/or treating mammals (e.g., humans) having prostate cancer. For example, methods and materials that can be used to determine whether or not a prostate cancer (e.g., a castration-resistant prostate cancer (CRPC)) is likely to respond to a particular cancer treatment (e.g., treatment with one or more inhibitors of a poly (ADP-ribose) polymerase (PARP) polypeptide) are provided. Methods and materials for using one or more cancer treatments to treat a mammal (e.g., a human) identified as likely to respond to a particular cancer treatment are also provided.